ESR1 gene amplification in breast cancer: a common phenomenon?
- 1 July 2008
- journal article
- Published by Springer Nature in Nature Genetics
- Vol. 40 (7) , 809
- https://doi.org/10.1038/ng0708-809a
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- BAC array CGH distinguishes mutually exclusive alterations that define clinicogenetic subtypes of gliomasInternational Journal of Cancer, 2007
- Estrogen receptor alpha (ESR1) gene amplification is frequent in breast cancerNature Genetics, 2007
- Identification of typical medullary breast carcinoma as a genomic sub-group of basal-like carcinomas, a heterogeneous new molecular entityBreast Cancer Research, 2007
- VAMP: Visualization and analysis of array-CGH, transcriptome and other molecular profilesBioinformatics, 2006
- Spatial normalization of array-CGH dataBMC Bioinformatics, 2006
- Two types of chromosome 1p losses with opposite significance in gliomasAnnals of Neurology, 2005
- Analysis of array CGH data: from signal ratio to gain and loss of DNA regionsBioinformatics, 2004
- ASK1 (MAP3K5) as a potential therapeutic target in malignant fibrous histiocytomas with 12q14–q15 and 6q23 amplificationsGenes, Chromosomes and Cancer, 2004
- Calibration of immunohistochemistry for assessment of HER2 in breast cancer: results of the French Multicentre GEFPICS* StudyHistopathology, 2003
- High sensitivity and specificity of immunohistochemistry for the detection of hormone receptors in breast carcinoma: comparison with biochemical determination in a prospective study of 793 casesHistopathology, 2000